[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
June 10, 1905


JAMA. 1905;XLIV(23):1860. doi:10.1001/jama.1905.02500500040010

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Dr. Anderson's article in this issue reports a very satisfactory state of affairs as regards the purity of vaccine material in this country. While the federal government can not constitutionally exercise any control over local municipal laboratories such as exist in some large cities, the benefits of its supervision in the management of the private firms engaged in the manufacture of vaccine and other organic therapeutic agents is very obvious. We would not wish to be understood as inferring that manufacturers would intentionally send out dangerous serums, etc., but the fact that one or two have been obliged to retire from business in this line shows what was needed in the way of government inspection. At present, it appears that the business is in good hands, yet the fact that with one exception there has been an improvement in the product since the inauguration of the government inspection is sufficiently

First Page Preview View Large
First page PDF preview
First page PDF preview